Published on in Vol 8, No 4 (2019): April

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/12125, first published .
Safety of Intranasal Ketamine for Reducing Uncontrolled Cancer-Related Pain: Protocol of a Phase I/II Clinical Trial

Safety of Intranasal Ketamine for Reducing Uncontrolled Cancer-Related Pain: Protocol of a Phase I/II Clinical Trial

Safety of Intranasal Ketamine for Reducing Uncontrolled Cancer-Related Pain: Protocol of a Phase I/II Clinical Trial

Jack W Shteamer   1 , MD ;   R Donald Harvey   2, 3 , PharmD ;   Boris Spektor   1 , MD ;   Kimberly Curseen   4 , MD ;   Katherine Egan   1 , BSN ;   Zhengjia Chen   5, 6 , PhD ;   Theresa W Gillespie   7 , BSN, MA, PhD ;   Roman M Sniecinski   1 , MD ;   Vinita Singh   1 , MD

1 Department of Anesthesiology, Emory University, Atlanta, GA, United States

2 Department of Pharmacology, Emory University, Atlanta, GA, United States

3 Department of Hematology and Medical Oncology, Emory University, Atlanta, GA, United States

4 Department of Medicine, Emory University, Atlanta, GA, United States

5 Department of Biostatistics and Bioinformatics, Emory University, Atlanta, GA, United States

6 Biostatistics and Bioinformatics Shared Resource, Winship Cancer Institute, Emory University, Atlanta, GA, United States

7 Department of Surgery, Emory University, Atlanta, GA, United States

Corresponding Author:

  • Jack W Shteamer, MD
  • Department of Anesthesiology
  • Emory University
  • 3B South, Emory University Hospital
  • 1364 Clifton Road, NE
  • Atlanta, GA, 30322
  • United States
  • Phone: 1 9132199504
  • Email: jshteam@emory.edu